European drug companies seek to end direct-to-consumer advertising ban; hope to follow U.S. drug advertising model
Citing a dearth of independent health information for consumers, European drug companies are aggressively lobbying for a change in E.U. rules about direct communication between companies and patients. But many watchdog groups fear that this is merely an attempt to bypass the E.U.'s ban on drug advertising. Concerned with a loss of profits to U.S. and Japanese drug companies, a group of industry and government representatives started a discussion forum in 2001 called G10 Medicines. The group concluded that profits would be increased if companies could communicate directly with patients. A resounding 70 percent of the European Parliament voted against this recommendation.
[ Ga naar het volledige artikel toe ]
Categorie: big pharma
[Reinig uw lichaam met de Chlorella alg -
100% plantaardig ]